儿童特应性皮炎合并症:一项基于人群的研究
该研究基于瑞典全国登记数据,纳入165145例儿童特应性皮炎(AD)患者及1:1匹配的非AD参考队列,比较多种过敏与非过敏合并症的发生风险。结果显示AD患者除1型糖尿病和骨骼疾病外,各合并症风险均升高,最高为过敏性疾病(HR 3.87),且风险随AD严重程度增加。
要点
- 儿童AD患者发生过敏性疾病风险最高(HR 3.87),其次为恶性肿瘤(HR 2.53)和免疫炎症性疾病(HR 2.36)。
- AD患者发生多种合并症(≥2种)的风险也升高。
- 合并症发生风险随AD严重程度加重而增加,活动期AD较缓解期风险更高。
核心结论
- 儿童AD患者除1型糖尿病和骨骼疾病外,多种合并症的发生风险均高于匹配的非AD参考队列。
- AD严重程度加重与合并症发生风险增加呈正相关。
研究设计与样本
- 瑞典全国性基于人群的队列研究,使用初级和专科医疗登记纵向数据。
- 纳入165145例AD患者(轻中度126681例,重度38464例)及1:1随机匹配的非AD参考队列。
主要发现
- 与参考队列相比,AD患者发生过敏性疾病风险最高(HR 3.87),其次为恶性肿瘤(HR 2.53)和免疫炎症性疾病(HR 2.36)。
- AD患者发生多种合并症(≥2种)的风险升高。
- 合并症发生风险随AD严重程度加重而增加,活动期AD患者较缓解期患者风险更高。
临床怎么用
- 儿童AD患者需关注过敏性疾病、恶性肿瘤及免疫炎症性疾病等合并症的筛查与管理。
- AD严重程度和活动状态可用于评估合并症发生风险。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atopic dermatitis (AD) is a chronic inflammatory skin disease that is associated with allergic comorbidities. However, studies examining comorbidities in childhood AD are incomplete, which may contribute to suboptimal care. OBJECTIVE: The objective was to compare the risk of developing different allergic and non-allergic comorbidities among children with AD to that of a matched non-AD reference cohort in Sweden. METHODS: This was a nationwide population-based cohort study using longitudinal data from primary and specialist care registers. Patients with AD were identified by confirmed diagnosis in primary or specialist care. The non-AD reference cohort was randomly drawn from the general population and matched 1:1 with the AD patients. The risk of developing the following conditions was evaluated: hypersensitivity and allergic disorders, neurological disorders, psychiatric disorders, infections, immunological and inflammatory disorders, Type 1 diabetes (T1D), endocrine and metabolic disorders, skeletal disorders, ocular disorders and malignancies. RESULTS: This study included 165,145 patients with AD (mild-to-moderate [n = 126,681] and severe [n = 38,464]) and an equally sized reference cohort. Patients with AD displayed a higher risk of developing comorbid conditions for all investigated categories, except for T1D and skeletal disorders, compared with the reference cohort. The highest risk compared with the reference cohort was observed for hypersensitivity and allergic disorders (hazard ratio [HR]: 3.87), followed by malignancies (HR: 2.53) and immunological and inflammatory disorders (HR: 2.36). Patients with AD also had higher risk of developing multiple comorbidities (≥2). The risk of comorbidity onset increased alongside AD severity and patients with active AD were associated with increased risk of comorbidity onset compared with patients in remission. CONCLUSIONS: The clinical burden of AD is substantial for children with AD and patients are at an increased risk of developing several comorbid conditions extending beyond the atopic march. Our results also showed a positive association between worsening severity of AD and an increased risk of comorbidity onset.
引用
- von Kobyletzki L, Henrohn D, Ballardini N, et al. Comorbidities in childhood atopic dermatitis: A population-based study. J Eur Acad Dermatol Venereol. 2023. PMID: 37824103. doi:10.1111/jdv.19569
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。